---
title: "Amgen Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286963683.md"
description: "Amgen Inc. (AMGN) shares rose 1.96% to $330.75 on a weak trading day for the market, breaking a three-day losing streak. Despite this gain, the stock remains 15.47% below its 52-week high of $391.29. Competitors like Johnson & Johnson, Pfizer, and AbbVie also saw gains, with trading volume surpassing its 50-day average."
datetime: "2026-05-19T20:34:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286963683.md)
  - [en](https://longbridge.com/en/news/286963683.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286963683.md)
---

# Amgen Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Amgen Inc. (AMGN) advanced 1.96% to $330.75 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.67% to 7,353.61 and Dow Jones Industrial Average falling 0.65% to 49,363.88.

The stock's rise snapped a three-day losing streak.

Amgen Inc. closed 15.47% short of its 52-week high of $391.29, which the company reached on March 2nd.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.47% to $230.00, Pfizer Inc. (PFE) rose 1.30% to $25.66, and AbbVie Inc. (ABBV) rose 2.08% to $213.76.

Trading volume (2.9 M) eclipsed its 50-day average volume of 2.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 19, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

05-19-26 1634ET

### Related Stocks

- [AMGN.US](https://longbridge.com/en/quote/AMGN.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [AMGEN ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER PETER GRIFFITH | AMGN Stock News](https://longbridge.com/en/news/286959850.md)
- [Amgen Announces CFO Transition and Leadership Succession Plan](https://longbridge.com/en/news/286964358.md)
- [Amgen says CFO Peter Griffith to retire, names Dittrich as successor](https://longbridge.com/en/news/286967989.md)
- [AbbVie Inc. $ABBV Shares Purchased by RiverFront Investment Group LLC](https://longbridge.com/en/news/286750290.md)
- [Acrivon Therapeutics, Inc. (ACRV) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286428001.md)